The Technical Analyst
Select Language :
Medlive Technology Co., [2192.HK]

Exchange: HKSE Sector: Healthcare Industry: Medical Distribution

Medlive Technology Co., Price, Forecast, Insider, Ratings, Fundamentals & Signals

Medlive Technology Co., is listed at the  Exchange

-0.46% HKD8.70

America/New_York / 3 mai 2024 @ 04:08


Medlive Technology Co.,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 6 324.57 mill
EPS: 0.360
P/E: 24.17
Earnings Date: Mar 25, 2024
SharesOutstanding: 726.96 mill
Avg Daily Volume: 0.490 mill
RATING 2024-05-02
A-
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Buy
DE: Sell
P/E: Buy
Price To Book: Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profitn/an/an/a
Ebitn/an/an/a
Asset n/an/an/a
Debt
PE RATIO: COMPANY / SECTOR
0.70x
Company: PE 24.17 | sector: PE 34.76
PE RATIO: COMPANY / INDUSTRY
1.83x
Company: PE 24.17 | industry: PE 13.23
DISCOUNTED CASH FLOW VALUE
HKD20.55
(136.17%) HKD11.85
Date: 2024-05-03
Expected Trading Range (DAY)

HKD 8.31 - 9.03

( +/- 4.20%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - HKD8.68
Forecast 2: 16:00 - HKD8.68
Forecast 3: 16:00 - HKD8.68
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price HKD8.70 (-0.46% )
Volume 0.585 mill
Avg. Vol. 0.490 mill
% of Avg. Vol 119.47 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Medlive Technology Co., Ltd.

Last 12 Months

Last 12 months chart data with high, low, open and close for Medlive Technology Co., Ltd.

RSI

Intraday RSI14 chart for Medlive Technology Co., Ltd.

Last 10 Buy & Sell Signals For 2192.HK

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Medlive Technology Co., Ltd.

2192.HK

Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, protocol design, medical monitoring, patient recruitment, and supporting system, as well as digital market research, electronic data capture, real-world studies, and application software development services. The company's medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies. Its intelligent patient management solution provides chronic disease management services, comprising online patient consultation, prescription services, and patient management through Internet hospital; and condition-specific patient education services, which includes content development, application software development, and other related services. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. Medlive Technology Co., Ltd. was founded in 1996 and is headquartered in Beijing, China.

Last 10 Buy Signals

Date Signal @
AUTO.OLMay 3 - 05:07NOK16.00
SCATC.OLMay 3 - 05:07NOK76.10
ODL.OLMay 3 - 05:05NOK51.20
SRBNK.OLMay 3 - 05:03NOK135.60
EQNR.OLMay 3 - 05:03NOK297.10
TONUSDMay 3 - 05:155.35
POLYXUSDMay 3 - 05:170.355
SUIUSDMay 3 - 05:161.096
LEOUSDMay 3 - 05:165.78
BFICUSDMay 3 - 05:169.89

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.